 |
Next Article 
The Journal of Neuroscience, July 15, 2002, 22(14):5791-5796
BRIEF COMMUNICATION
Phosphorylation of the Postsynaptic Density-95 (PSD-95)/Discs
Large/Zona Occludens-1 Binding Site of Stargazin Regulates
Binding to PSD-95 and Synaptic Targeting of AMPA Receptors
Dane M.
Chetkovich1, *,
Lu
Chen2, *,
Timothy J.
Stocker3,
Roger A.
Nicoll2, 3, and
David S.
Bredt3
Departments of 1 Neurology, 2 Cellular and
Molecular Pharmacology, and 3 Physiology, University of
California at San Francisco, San Francisco, California 94143
 |
ABSTRACT |
Dynamic regulation of AMPA-type receptors at the synapse is
proposed to play a critical role in alterations of the synaptic strength seen in cellular models of learning and memory such as long-term potentiation in the hippocampus. Stargazin, previously identified as an AMPA receptor (AMPAR)-interacting protein, is critical
for surface expression and synaptic targeting of AMPARs. Stargazin
interacts with postsynaptic density-95/discs large/zona occludens-1 (PDZ) proteins via a C-terminal PDZ binding motif. Interestingly, the C terminal of stargazin also predicts
phosphorylation at a threonine residue critical for PDZ protein
binding. Because protein phosphorylation regulates synaptic plasticity,
we characterized this site and the effects of stargazin phosphorylation
on AMPAR function. In vitro peptide
phosphorylation assays and Western blot analysis with
phospho-stargazin-specific antibodies indicate that the critical
threonine within the stargazin PDZ binding site is phosphorylated by
protein kinase A. This phosphorylation disrupts stargazin interaction
and clustering with postsynaptic density-95 (PSD-95) in transfected
COS-7 cells. Furthermore, a stargazin construct with a
Thr-to-Glu mutation that mimics phosphorylation fails to cluster at
synaptic spines and downregulates synaptic AMPAR function in cultured
hippocampal neurons. These data suggest that phosphorylation of the
stargazin PDZ ligand can disrupt stargazin interaction with PSD-95 and
thereby regulate synaptic AMPAR function.
Key words:
AMPA receptors; PSD-95; PDZ domain; phosphorylation; glutamate; plasticity
 |
INTRODUCTION |
Glutamate receptors (GluRs)
mediate most excitatory synaptic transmission in the brain. There are
two major classes of ionotropic receptors at glutamatergic synapses,
NMDA receptors (NMDARs) and AMPA receptors (AMPARs). AMPARs
mediate rapid synaptic transmission, whereas activation of
calcium-permeable NMDARs induces synaptic plasticity (Madison et al.,
1991 ; Nakanishi, 1992 ; Bliss and Collingridge, 1993 ; Seeburg, 1993 ;
Hollmann and Heinemann, 1994 ). Both AMPA and NMDARs are highly
concentrated at the postsynaptic density (PSD) of excitatory synapses,
yet there are remarkable differences in the synaptic anchoring of NMDA
and AMPARs. Whereas NMDARs are stable components of the PSD, AMPARs
recycle rapidly; changes in the synaptic expression of AMPARs regulate
aspects of synaptic plasticity (Song et al., 1998 ; Luthi et al., 1999 ;
Ehlers, 2000 ; Liu and Cull-Candy, 2000 ; Lüscher et al., 2000 ;
Malinow et al., 2000 ; Man et al., 2000 ).
This differential behavior of synaptic AMPA versus NMDAR proteins
likely reflects their different anchoring mechanisms at the PSD,
because the cytosolic C-terminal tails of AMPA and NMDARs associate
with distinct PSD-95/discs large/zona occludens-1 (PDZ) domain-containing synaptic scaffolding proteins (Kornau et al., 1997 ;
Ziff, 1997 ; Garner et al., 2000 ). The C termini of NMDAR NR2 subunits
(SIESDV) bind to PDZ domains of the PSD-95/synapse-associated protein-90 family of membrane-associated guanylate kinases
(Kornau et al., 1997 ; Garner et al., 2000 ). In contrast, the C-terminal tail of GluR2 (IESVKI) binds to PDZ domains from several proteins, including protein interacting with C kinase 1 (PICK1), glutamate receptor interacting protein (GRIP), and AMPA receptor binding protein (Srivastava et al., 1998 ; Kim and Huganir, 1999 ).
AMPAR subunits also interact with stargazin (Chen et al., 2000 ), the
protein that is mutated in epileptic stargazer mice (Letts et al.,
1998 ). Stargazin has a cytosolic C-terminal tail containing a PDZ
binding site (RRTTPV) that interacts with PSD-95 (Chen et al., 2000 ).
Stargazin is enriched in cerebellar granule cells, and AMPARs fail to
traffic to the plasma membrane or to the synapse in stargazer mutant
granule cells. Stargazin-like mechanisms may also regulate AMPARs in
the forebrain, because overexpression of a dominant negative stargazin
construct reduces synaptic AMPAR function in hippocampal neurons (Chen
et al., 2000 ). Therefore, these previous studies identify a
necessary role for stargazin in plasma membrane expression of AMPARs.
How stargazin regulates cycling of AMPARs remains unclear (Tomita et
al., 2001 ).
Protein phosphorylation plays a central role in controlling AMPAR
expression at the synapse and in regulating synaptic strength (Lüscher et al., 1999 ; Lee et al., 2000 ; Malinow et al., 2000 ; Soderling, 2000 ). Interestingly, stargazin and its close homologs all
contain a consensus sequence for protein kinase phosphorylation within
their PDZ binding site. Therefore, we explored phosphorylation of this
site and its possible regulation of AMPAR trafficking. We found that
the critical threonine within the stargazin PDZ binding site can be
phosphorylated by protein kinase A (PKA). This phosphorylation disrupts
stargazin interaction and clustering with PSD-95. Stargazin with a
Thr-to-Glu mutation that mimics phosphorylation does not
cluster at synapses; this phospho-mimic blocks the synaptic function
of AMPARs in transfected neurons. These data suggest that
phosphorylation of the stargazin PDZ ligand provides a mechanism for
disrupting stargazin interaction with PSD-95, thereby regulating
synaptic AMPARs.
 |
MATERIALS AND METHODS |
Antibodies. The stargazin C-terminal peptide
star(313-323) and its phospho-amino acid (Thr321) analog
phospho-star(313-323), coupled to the maleimide-activated keyhole
limpet hemocyanin, were used for rabbit immunization.
In vitro kinase assays. Kinase reactions were done in 50 µl of assay buffer containing [final concentration: 25 mM MES, pH 6.0, 1 mM EDTA,
1 mM EGTA, 1 mM
-mercaptoethanol, 0.05% Triton X-100, protease inhibitors (10 µg/ml leupeptin and 2 µg/ml aprotinin), phosphatase inhibitors (2 mM
Na4P2O7
and 10 µM NaF), 5 mM
MgCl2, 20 µM ATP, and
~3000 cpm/pmol [ -32P]ATP]. Peptide
substrates were added at a final concentration of 500 µM. The peptide substrates used included
Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide; Sigma, St. Louis, MO),
Met-Asp-Cys-Leu-Cys-Ile-Val-Thr-Thr-Lys-Lys-Tyr-Arg-Tyr-Gln-Asp-Glu-Asp-Thr-Pro (PSD-95 1-20; Research Genetics, Huntsville, AL), and the stargazin C-terminal peptides described above. Reactions were performed at 30°C
for 5 min and stopped with 25 µl of ice-cold stop solution (225 mM
H3PO4 and 1 mM ATP). Aliquots were spotted onto duplicate phosphocellulose paper strips, washed, and counted.
cDNA cloning and mutagenesis. Constructs coding for PSD-95,
Kv1.4, and stargazin, as well as their
green fluorescent protein (GFP) or hemagglutinin (HA)
fusions, have been described previously (Topinka and Bredt, 1998 ;
Craven et al., 1999 ). Stargazin(T321E) and stargazin(R318,319A) were
generated by PCR using standard methods.
Yeast two-hybrid assays. Directed yeast two-hybrid assays
were performed using the Matchmaker kit (Becton Dickinson, San Jose, CA), according to the manufacturer's protocols. Briefly,
engineered stargazin constructs described above were transformed into
yeast (AH109) with PDZ I-III of PSD-95 under appropriate selection. Interaction was scored as positive when colonies grew on media lacking
Leu, Trp, His, and adenine.
Cell transfection and immunofluorescence labeling.
COS-7 cells were grown and transfected using Lipofectamine
reagent as described previously (Chen et al., 2000 ). Hippocampal
cultures were maintained, transfected, and stained as described
previously (Craven et al., 1999 ).
Electrophysiology. Whole-cell patch-clamp recordings were
performed on cultured neurons as described previously (Chen et al., 2000 ).
 |
RESULTS |
The consensus sequence for phosphorylation by PKA is
Arg-Arg-Xxx-Ser/Thr, which is precisely conserved at the C termini of the stargazin family of proteins (Fig.
1A). Using in
vitro peptide kinase assays (Fig. 1B), we found
that the stargazin C terminal is phosphorylated by PKA. Phosphorylation
of the stargazin peptide occurs specifically on the Thr at position 2
(T321E); a synthetic peptide phosphorylated at this Thr is not a
substrate for PKA (Fig. 1B).

View larger version (47K):
[in this window]
[in a new window]
|
Figure 1.
Stargazin is phosphorylated at the PDZ binding
site by PKA. A, The C-terminal amino acid sequence of
stargazin ( 2) as well as other stargazin family members that contain
predicted PDZ binding domains. The PDZ binding domain is highlighted in
gray, the protein kinase consensus phosphorylation
sequence is bordered by a rectangle, and the predicted
phosphorylation site and critical PDZ-binding residue are in
bold type. B, Peptide substrates were
incubated with PKA and [ -32P]ATP in
vitro. Although peptides corresponding to the N-terminal 20 aa
of PSD-95 [PSD-95(1-20)] and the C terminal of
stargazin phosphorylated at the 2 threonine residue
[phospho-stargazin(313-323)] were not phosphorylated,
the C terminus of stargazin [stargazin(313-323)] was
phosphorylated. Data are presented as counts per minute and represent
the average of four experiments ± SEM. *p < 0.001. C, Stargazin(313-323) and
phospho-stargazin(313-323) were coupled to BSA, spotted on
polyvinylidene difluoride membranes, and immunoprobed.
Antibodies prepared to phospho-stargazin(313-323) were 100-fold more
sensitive for the phosphorylated peptide compared with the
nonphosphorylated peptide. D, COS-7 cells were
transfected with stargazin-GFP (star-GFP) in the
presence or absence of PKA-GFP; cell lysates were prepared and
subjected to SDS-PAGE and Western blotting with stargazin and
phospho-stargazin antibodies. Cotransfection with PKA dramatically
increased the phosphorylation of stargazin, an effect that was
eliminated by treatment of the lysates with -phosphatase.
|
|
To evaluate possible phosphorylation of this site in intact cells, we
generated a phospho-specific antibody to the C terminal of stargazin.
We characterized the specificity of this phospho-antibody by dot blot
analysis. As shown in Figure 1C, the phospho-specific antibody shows ~100-fold greater reactivity with the phosphorylated stargazin C-terminal peptide compared with the nonphosphorylated peptide. To evaluate possible phosphorylation of stargazin in intact
cells, we transfected COS-7 cells with stargazin and probed immunoblots
with the phospho-specific antibody. We found that the PDZ binding site
of stargazin is basally phosphorylated in transfected cells. This basal
phosphorylation of stargazin is dramatically enhanced by cotransfecting
COS-7 cells with the catalytic subunit of PKA. The phospho-specific
antibody reacts only with phosphorylated stargazin, because treating
the cell extracts with -phosphatase eliminates the reactive band.
Because the PKA phosphorylation site at the C terminal of stargazin
overlaps with the PDZ binding site (Fig. 1A), one
might predict that this phosphorylation would disrupt binding to
PSD-95. To test this, we first generated a phospho-mimic construct in which the Thr residue (T321) is mutated to Glu (E). This sort of
Thr-to-Glu mutation often simulates the effect of phosphorylation by
imparting an appropriate negative charge. To test directly whether this construct binds PSD-95, we performed
coimmunoprecipitation assays in transfected COS-7 cells. Although
wild-type stargazin interacts strongly with PSD-95, the
stargazin(T321E) construct showed no interaction (Fig.
2A). Furthermore, in
the yeast two-hybrid assay, the stargazin T321E mutation disrupts
binding to the PDZ domains of PSD-95 (Fig. 2B). To
test whether phosphorylation of this site regulates binding in intact
cells, we used a clustering assay in heterologous cells. COS-7 cells
were first transfected with either stargazin-GFP, stargazin(T321E)-GFP,
stargazin(R318,319A)-GFP, or PSD-95. In these single transfections,
each protein showed a generally diffuse distribution with some
perinuclear accumulation (data not shown). Cotransfection
of PSD-95 with stargazin-GFP produced characteristic patchy clusters of
both proteins (Fig. 3A-C),
which are on the plasma membrane, as we demonstrated previously (Chen
et al., 2000 ). In contrast, cotransfection of phospho-mimic stargazin(T321E) with PSD-95 showed diffuse staining of both
proteins throughout the cell (Fig. 3D-F). To assess
the role of PKA directly, we transfected cells with PSD-95, stargazin,
and PKA-GFP. In these triple transfections, PKA eliminates the
clustering of stargazin by PSD-95 (Fig. 3G-I). To
control for the effects of PKA, we mutated the pair of Arg residues
in the C-terminal tail of stargazin to Ala. This
stargazin(R318,319A)-GFP lacks the consensus sequence for PKA
phosphorylation but still binds to PSD-95. We found that this construct
clusters with PSD-95 (Fig. 3J-L). Furthermore, whereas PKA
diminishes the PSD-95-mediated clustering of stargazin, PKA has no
effects on the clustering of stargazin(R318,319A) by PSD-95 (Fig.
3M).

View larger version (46K):
[in this window]
[in a new window]
|
Figure 2.
The phospho-mimic stargazin does not interact with
PSD-95. A, COS-7 cells were transfected alone or with
the indicated combinations of stargazin-GFP (star-GFP),
PSD-95, and stargazin(T321E)-GFP [star(T321E)-GFP];
cell lysates were prepared, and PSD-95 was immunoprecipitated
(IP). Whereas stargazin-GFP interacted strongly
with PSD-95, stargazin(T321E)-GFP failed to coimmunoprecipitate.
B, Interaction of stargazin constructs with the PDZ
domains of PSD-95. Yeasts were transformed with plasmids encoding the C
terminal of stargazin [stargazin(201-323)], stargazin missing the
last four amino acids [stargazin(201-319)], or the phospho-mimic
stargazin [stargazin(201-323,T321E)], together with PDZ domains
I-III of PSD-95. The stargazin C termini were fused to the
galactosidase-4 (GAL4) DNA binding domain and the PDZ domains
were fused to the GAL4 activation domain. Colonies that grew on plates
lacking Leu, Trp, adenine, and His were scored as positive (+).
|
|

View larger version (49K):
[in this window]
[in a new window]
|
Figure 3.
Phosphorylation of the stargazin PDZ
ligand disrupts clustering with PSD-95. COS-7 cells were transfected
with combinations of stargazin-GFP, stargazin-HA, PSD-95,
stargazin(T321E)-GFP, stargazin(R318,319A)-GFP, and PKA-GFP.
A-C, When cotransfected, PSD-95 and stargazin-GFP
cocluster in large plasma membrane patches. D-F,
Stargazin(T321E)-GFP remains diffusely localized when transfected with
PSD-95. G-I, Transfection of PKA-GFP with stargazin-HA
and PSD-95 results in the diffuse localization of stargazin.
J-L, Stargazin(R318,319A)-GFP, a construct that
contains a mutated PKA recognition site, is clustered by PSD-95 in
COS-7 cells. Merged images are shown in the panels on
the right (C, F, I, L). Scale bar, 10 µM. M, COS-7 cells were transfected with
PSD-95 and the indicated constructs. star, Stargazin-HA;
star(T-E), stargazin(T321E)-HA;
star(R-A), stargazin(R318,319A)-HA. Surface clustering
was assessed in 100 randomly selected cells in four separate
experiments. Although PSD-95-mediated clustering of stargazin-HA is
reduced by PKA-GFP, there is no effect on PSD-95-mediated clustering of
stargazin(R318,319A)-HA or Kv1.4-HA. *p < 0.001.
|
|
Phosphorylation of stargazin at T321 interferes with the
PSD-95-mediated clustering of stargazin. In addition, Choi et al. (2002) used a phospho-specific antibody to show that stargazin phosphorylated at T321 is enriched in a soluble, nonsynaptic fraction in the brain. To assess the effect of PKA phosphorylation in the synaptic targeting of stargazin, we transfected hippocampal neurons with GFP-tagged stargazin constructs. Whereas wild-type stargazin clusters at postsynaptic sites in hippocampal neurons (Fig.
4A-C), stargazin(T321E) with the phospho-mimic at the PKA site showed diffused
staining throughout the neuron (Fig. 4D-F).
This suggests that phosphorylation of the C-terminal site blocks the
synaptic targeting of stargazin. However, the stargazin(R318,319A)
construct that lacked the C-terminal PKA phosphorylation site clustered normally in hippocampal neurons (Fig. 4G-I),
suggesting that the phosphorylation of stargazin at the C terminus is
not necessary for stargazin synaptic targeting.

View larger version (28K):
[in this window]
[in a new window]
|
Figure 4.
Phospho-mimic stargazin does not traffic to the
synapse and attenuates synaptic AMPAR currents. Constructs encoding
stargazin-GFP, stargazin(T321E)-GFP, or stargazin(R318,319A)-GFP
(green) were transfected into neurons, which were
then fixed and stained for PSD-95 (red) after 11-17 d
in vitro. Stargazin-GFP clusters at synaptic sites
(A-C). The phospho-mimic stargazin,
stargazin(T321E)-GFP, does not target to synapses
(D-F), whereas stargazin(R318,319A)-GFP, a
construct that contains a mutated PKA recognition site, retains
synaptic localization (G-I). Merged images are
shown in the panels on the right
(C, F, I). Scale bar, 10 µM. In
separate experiments, cultured neurons were transfected with
stargazin(T321E)-GFP or stargazin(R318,319A)-GFP and synaptic currents
were measured by whole-cell patch-clamp recording at a holding
potential of 60 mV. Stargazin(T321E)-GFP transfection
downregulates AMPAR mEPSC amplitude (p < 0.002) in hippocampal neurons (J), whereas
stargazin(R318,319A)-GFP has no effect
(K).
|
|
To determine whether phosphorylation of stargazin at the C terminus
might play a role in the modulation of AMPAR EPSCs, we transfected cultured hippocampal neurons with the phospho-mimic stargazin(T321E) and evaluated miniature EPSCs (mEPSCs)
with whole-cell patch clamp recordings. Stargazin(T321E) expression
markedly diminished the amplitude of AMPAR mEPSCs compared with
neighboring untransfected neurons (Fig. 4J)
[stargazin(T321E), 11.6 ± 2.1 pA, n = 5;
untransfected controls, 34.7 ± 4.9 pA, n = 4;
p < 0.002]. In addition, the frequency of
mEPSCs was reduced in transfected cells [controls, 11.7 ± 4.0 Hz, n = 4; stargazin(T321E), 3.1 ± 1.2 Hz pA,
n = 5; p < 0.05].
We also evaluated the effect of transfection of the
stargazin(R318,319A) construct lacking the C-terminal PKA
phosphorylation site on AMPAR function. This construct had no effect on
AMPAR spontaneous EPSC (sEPSC) amplitude in cultured granule
cells (Fig. 4J) [stargazin(R318,319A), 12.9 ± 2.5 pA, n = 5; untransfected controls, 11.6 ± 1.7 pA, n = 9; p > 0.5].
Furthermore, transfection with this construct had no effect on sEPSC
frequency [stargazin(R318,319A), 1.2 ± 0.3 Hz, n = 5; untransfected controls, 2.2 ± 0.6 Hz, n = 9;
p > 0.2].
 |
DISCUSSION |
PDZ domains are small modular protein-protein interaction
interfaces that have emerged as critical regulators of protein
clustering at synapses and other sites of cell-cell contact (Kornau et
al., 1997 ; Ziff, 1997 ; Craven and Bredt, 1998 ; Garner et al., 2000 ; Kennedy, 2000 ; Sheng and Sala, 2001 ). PSD-95 is the major PDZ protein
at excitatory synapses in the brain (Kornau et al., 1997 ; Ziff, 1997 ;
Craven and Bredt, 1998 ; Garner et al., 2000 ; Kennedy, 2000 ; Sheng and
Sala, 2001 ), and PSD-95 binds directly to the C-terminal tail of NMDARs
(Kornau et al., 1997 ). However, overexpression of PSD-95 in hippocampal
neurons enhances synaptic AMPARs (El-Husseini et al., 2000 ). A possible
link between PSD-95 and AMPARs is the AMPAR-interacting protein
stargazin, a four-pass transmembrane protein that contains a PDZ
binding site (Chen et al., 2000 ). A consensus sequence for protein
phosphorylation overlaps the PDZ binding site; this C-terminal cassette
is precisely conserved in a family of stargazin-like proteins (Burgess
et al., 1999 ; Klugbauer et al., 2000 ). In this study, we investigated
whether phosphorylation of the C-terminal tail of stargazin might
regulate its interaction with PSD-95. We found that this site in
stargazin is basally phosphorylated in transfected cells and that this
phosphorylation is increased by PKA activity. Phosphorylation of the
C-terminal PDZ ligand blocks stargazin binding to and clustering with
PSD-95.
Disruption of PSD-95 binding by phosphorylation of the stargazin C
terminal can be explained by the crystal structure of the PDZ domain
(Doyle et al., 1996 ), which shows that Thr in the 2 peptide position
(the residue phosphorylated in stargazin) forms a critical hydrogen
bond to a conserved His residue in the PDZ domain. Phosphorylation of
this Thr would disrupt the hydrogen bonding and prevent specific
binding. In agreement with our results, previous studies have shown
that phosphorylation of inwardly rectifying K+ channels (Kir2.0) and
2-adrenergic receptors at analogous positions in their PDZ binding sites disrupts their binding to type I PDZ domains
(Cohen et al., 1996 ; Cao et al., 1999 ).
By disrupting its interaction with PSD-95, phosphorylation of the
stargazin PDZ domain regulates its synaptic function. Synaptic targeting of AMPARs by stargazin involves two distinct mechanisms (Chen
et al., 2000 ). In cerebellar granular cells from stargazer mice,
functional AMPARs are absent from both synaptic and extrasynaptic locations. Intact stargazin can rescue both the synaptic and
extrasynaptic AMPARs, whereas stargazin lacking the PDZ binding site
selectively rescues extrasynaptic but not synaptic receptors. These
data implicate the C terminal of stargazin specifically in the synaptic
targeting of stargazin and its associated AMPARs. Here we find that
stargazin with a mimic of constitutive phosphorylation at the C
terminal acts as a dominant negative to suppress synaptic AMPAR
function when transfected into wild-type neurons.
Paralleling these effects on synaptic AMPARs, we find that the
phospho-mimic mutation disrupts synaptic clustering of stargazin in
hippocampal neurons. These data suggest that phosphorylation of the PDZ
binding ligand of stargazin is a regulator of synaptic levels of AMPARs
and synaptic strength.
Recent studies (Song et al., 1998 ; Luthi et al., 1999 ; Ehlers, 2000 ;
Liu and Cull-Candy, 2000 ; Lüscher et al., 2000 ; Malinow et al.,
2000 ; Man et al., 2000 ) indicate that changes in the synaptic levels of
AMPARs represent a primary mechanism for the rapid modulation of
synaptic efficacy, as occurs in some forms of long-term potentiation (LTP) and long-term depression (LTD). Protein phosphorylation cascades
play an integral role in this regulation. At hippocampal CA3 to CA1
synapses, LTP requires postsynaptic Ca/calmodulin-dependent protein
kinase II (CaMKII) activity, whereas LTD involves the activation
of postsynaptic protein phosphatase cascades (Lee et al., 2000 ;
Lüscher et al., 2000 ; Malinow et al., 2000 ; Soderling, 2000 ).
However, at cerebellar parallel fiber to Purkinje cell synapses,
LTD requires postsynaptic PKC activity (Xia et al., 2000 ). The role for
PKA in early phase postsynaptic LTP is less well defined; however,
recent studies have shown that LTP at depotentiated hippocampal CA3 to
CA1 synapses is specifically reduced by PKA inhibitors (Lee et al.,
2000 ). In this light, it may be surprising that phosphorylation of the
C-terminal site in stargazin reduces synaptic expression of stargazin
and disrupts the synaptic targeting of AMPARs. However, as discussed
above, protein kinase regulation of AMPAR levels depends critically on
the neuronal type and history of the synapse. Future experiments are
needed to determine where and when stargazin phosphorylation integrates
into the complex regulatory web.
An alternative model to explain the unexpected consequence of
stargazin C-terminal phosphorylation is that other phosphorylation sites in the AMPAR synaptic complex play an overriding role in AMPAR
functional modulation. Along these lines, AMPAR function can be
potentiated by PKA phosphorylation of serine 845 or by CaMKII or PKC
phosphorylation of serine 831 on the intracellular C-terminal tail of
the GluR1 subunit of the AMPAR (Roche et al., 1996 ; Lee et al., 2000 ).
Furthermore, phosphorylation of the C terminal of the GluR2 subunit of
the AMPAR by PKC has been implicated in de-depression from LTD (Daw et
al., 2000 ). Interestingly, GluR2 phosphorylation by PKC modulates its
interactions with the PDZ proteins GRIP1 and PICK1, and PKC-stimulated
changes in GRIP1 and PICK1 binding have been implicated in the
trafficking of synaptic AMPARs (Chung et al., 2000 ). Thus, there are
multiple phosphorylation substrates that may have differing importance
in AMPAR function, depending on kinases, GluR subunits, and the
presence or absence of different AMPAR-binding proteins.
Although in our experiments, the C-terminal stargazin phospho-mimic did
not target to synapses, it is possible that under physiological
circumstances stargazin is phosphorylated after arrival at the synapse.
Consistent with this model, we were unable to demonstrate any effect on
the synaptic localization of transfected stargazin after stimulation of
cultured neurons for up to 30 min with forskolin (10 µM)
and 3-isobutyl-1-methylxanthine (1 mM) (data not
shown). Given that GluR2 phosphorylation by PKC can alter its PDZ
protein binding specificity, it is interesting to speculate that
stargazin phosphorylation at the C terminal might decrease PSD-95
binding but retain binding to a different interacting molecule or to a
less-selective PDZ protein present at the synapse. We have shown
previously that stargazin lacking the C-terminal PDZ binding domain
retains interaction with GluR subunits (Chen et al., 2000 ). This
observation raises the possibility that phosphorylation at the synapse
could release the stargazin/AMPAR from a PDZ-bound state to one in
which the mobility of the complex is defined by GluR subunit
interaction with proteins such as GRIP1 and PICK1. An alternative
explanation for the lack of effect of the pharmacological activation of
PKA is that the stargazin phosphorylation site is masked when bound to
PSD-95 at synapses, or that exogenous activation of PKA may not behave
like endogenous activation. Additional experiments are necessary to
determine the role that other stargazin binding partners play in
stargazin phosphorylation, as well as stargazin synaptic targeting and
AMPAR function.
The specific signal transduction cascades that regulate stargazin
phosphorylation in neurons remain uncertain. We were unable to
detectably alter the phosphorylation of stargazin by treating cultured
hippocampal neurons or hippocampal slices with glutamate (data not
shown). These results may reflect technical limitations of this
approach or may suggest that activation of excitatory synapses is not
directly linked to stargazin phosphorylation. While this manuscript was
in preparation, a study published results consistent with our present
findings and also showed that stargazin phosphorylated at Thr321 occurs
in a soluble fraction exclusive of most PSD proteins (Choi et al.,
2002 ). This observation suggests that synaptic phosphorylation removes
stargazin from a PSD-bound state, or alternatively, that cellular
rather than synaptic signaling cascades regulate the phosphorylation of
stargazin. Finally, the phosphorylation site at the C terminal of
stargazin is a consensus for a variety of protein kinases and may be
phosphorylated by distinct kinases, depending on the specific cellular
and physiological context. Basic amino acids preceding the
phosphorylated Thr make this site a candidate for phosphorylation not
only by PKA but also by protein kinase G, protein kinase C, and CaMKII.
Because proline follows the Thr321, this site may also be
phosphorylated by proline-directed kinases, including MAP kinase and
cdk5. Additional work is needed to determine the specific signaling
cascades that mediate phosphorylation of the stargazin PDZ binding
sites and how this participates in the regulation of AMPARs to control
synaptic strength and plasticity.
 |
FOOTNOTES |
Received March 21, 2002; revised April 24, 2002; accepted April 29, 2002.
*
D.M.C. and L.C. contributed equally to this work.
This work was supported by grants from the National Institutes of
Health (D.S.B, R.A.N., D.M.C. L.C.), the Howard Hughes Medical Institute Research Resources Program (D.S.B.), the Christopher Reeve
Paralysis Foundation (D.S.B.), the Human Frontier Research Program
(D.S.B.), Bristol-Myers-Squibb Company (R.A.N.), and the National
Association for Research on Schizophrenia and Depression (D.M.C.).
R.A.N. is a member of the Keck Center for Integrative Neuroscience and
the Silvo Conte Center for Neuroscience Research. D.S.B. is an
established investigator for the American Heart Association.
This work was presented in abstract form at the Society for
Neuroscience annual meeting, November 2001.
Correspondence should be addressed to Dr. David S. Bredt, University of
California at San Francisco School of Medicine, Box 0444, 513 Parnassus
Avenue, San Francisco, CA 94143-0444. E-mail: bredt{at}itsa.ucsf.edu.
 |
REFERENCES |
-
Bliss TV,
Collingridge GL
(1993)
A synaptic model of memory: long-term potentiation in the hippocampus.
Nature
361:31-39[Medline].
-
Burgess DL,
Davis CF,
Gefrides LA,
Noebels JL
(1999)
Identification of three novel Ca(2+) channel gamma subunit genes reveals molecular diversification by tandem and chromosome duplication.
Genome Res
9:1204-1213[Abstract/Free Full Text].
-
Cao TT,
Deacon HW,
Reczek D,
Bretscher A,
von Zastrow M
(1999)
A kinase-regulated PDZ-domain interaction controls endocytic sorting of the
2-adrenergic receptor.
Nature
401:286-290[Medline]. -
Chen L,
Chetkovich DM,
Petrailia RS,
Sweeney NT,
Kawaski Y,
Wenthold R,
Bredt DS,
Nicoll RA
(2000)
Stargazin mediates synaptic targeting of AMPA receptors by two distinct mechanisms.
Nature
408:936-943[Medline].
-
Choi J,
Ko J,
Park E,
Lee JR,
Yoon J,
Lim S,
Kim E
(2002)
Phosphorylation of stargazin by PKA regulates its interaction with PSD-95.
J Biol Chem
277:12359-12363[Abstract/Free Full Text].
-
Chung HJ,
Xia J,
Scannevin RH,
Zhang X,
Huganir RL
(2000)
Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins.
J Neurosci
20:7258-7267[Abstract/Free Full Text].
-
Cohen NA,
Brenman JE,
Snyder SH,
Bredt DS
(1996)
Binding of the inward rectifier K+ channel Kir 2.3 to PSD-95 is regulated by protein kinase A phosphorylation.
Neuron
17:759-767[ISI][Medline].
-
Craven SE,
Bredt DS
(1998)
PDZ proteins organize synaptic signaling pathways.
Cell
93:495-498[ISI][Medline].
-
Craven SE,
Husseini AE,
Bredt DS
(1999)
Synaptic targeting of the postsynaptic density protein PSD-95 mediated by lipid and protein motifs.
Neuron
22:497-509[ISI][Medline].
-
Daw MI,
Chittajallu R,
Bortolotto ZA,
Bortolotto D,
Duprat F,
Henley JM,
Collingridge GL,
Isaac JT
(2000)
PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses.
Neuron
28:873-886[ISI][Medline].
-
Doyle DA,
Lee A,
Lewis J,
Kim E,
Sheng M,
MacKinnon R
(1996)
Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ.
Cell
85:1067-1076[ISI][Medline].
-
Ehlers MD
(2000)
Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting.
Neuron
28:511-525[ISI][Medline].
-
El-Husseini AE,
Schnell E,
Chetkovich DM,
Nicoll RA,
Bredt DS
(2000)
PSD-95 involvement in maturation of excitatory synapses.
Science
290:1364-1368[Abstract/Free Full Text].
-
Garner CC,
Nash J,
Huganir RL
(2000)
PDZ domains in synapse assembly and signalling.
Trends Cell Biol
10:274-280[ISI][Medline].
-
Hollmann M,
Heinemann S
(1994)
Cloned glutamate receptors.
Annu Rev Neurosci
17:31-108[ISI][Medline].
-
Kennedy MB
(2000)
Signal-processing machines at the postsynaptic density.
Science
290:750-754[Abstract/Free Full Text].
-
Kim JH,
Huganir RL
(1999)
Organization and regulation of proteins at synapses.
Curr Opin Cell Biol
11:248-254[ISI][Medline].
-
Klugbauer N,
Dai S,
Specht V,
Lacinová L,
Marais E,
Bohn G,
Hofmann F
(2000)
A family of gamma-like calcium channel subunits.
FEBS Lett
470:189-197[ISI][Medline].
-
Kornau H-C,
Seeburg PH,
Kennedy MB
(1997)
Interaction of ion channels and receptors with PDZ domains.
Curr Opin Neurobiol
7:368-373[ISI][Medline].
-
Lee HK,
Barbarosie M,
Kameyama K,
Bear MF,
Huganir RL
(2000)
Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity.
Nature
405:955-959[Medline].
-
Letts VA,
Felix R,
Biddlecome GH,
Arikkath J,
Mahaffey CL,
Valenzuela A,
Bartlett II FS,
Mori Y,
Campbell KP,
Frankel WN
(1998)
The mouse stargazer gene encodes a neuronal Ca2+-channel
-subunit.
Nat Genet
19:340-347[ISI][Medline]. -
Liu SQ,
Cull-Candy SG
(2000)
Synaptic activity at calcium-permeable AMPA receptors induces a switch in receptor subtype.
Nature
405:454-458[Medline].
-
Lüscher C,
Nicoll RA,
Malenka RC,
Muller D
(2000)
Synaptic plasticity and dynamic modulation of the postsynaptic membrane.
Nat Neurosci
3:545-550[ISI][Medline].
-
Lüscher C,
Xia H,
Beattie EC,
Carroll RC,
von Zastrow M,
Malenka RC,
Nicoll RA
(1999)
Role of AMPA receptor cycling in synaptic transmission and plasticity.
Neuron
24:649-658[ISI][Medline].
-
Luthi A,
Chittajallu R,
Duprat F,
Palmer MJ,
Benke TA,
Kidd FL,
Henley JM,
Isaac JT,
Collingridge GL
(1999)
Hippocampal LTD expression involves a pool of AMPARs regulated by the NSF-GluR2 interaction.
Neuron
24:389-399[ISI][Medline].
-
Madison DV,
Malenka RC,
Nicoll RA
(1991)
Mechanisms underlying long-term potentiation of synaptic transmission.
Annu Rev Neurosci
14:379-397[ISI][Medline].
-
Malinow R,
Mainen ZF,
Hayashi Y
(2000)
LTP mechanisms: from silence to four-lane traffic.
Curr Opin Neurobiol
10:352-357[ISI][Medline].
-
Man YH,
Lin JW,
Ju WH,
Ju A,
Liu L,
Becker LE,
Sheng M,
Wang YT
(2000)
Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization.
Neuron
25:649-662[ISI][Medline].
-
Nakanishi S
(1992)
Molecular diversity of glutamate receptors and implications for brain function.
Science
258:597-603[Abstract/Free Full Text].
-
Roche WK,
O'Brien RJ,
Mammen AL,
Bernhardt J,
Huganir RL
(1996)
Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit.
Neuron
16:1179-1188[ISI][Medline].
-
Seeburg PH
(1993)
The TINS/TiPS lecture. The molecular biology of mammalian glutamate receptor channels.
Trends Neurosci
16:359-365[ISI][Medline].
-
Sheng M,
Sala C
(2001)
PDZ domains and the organization of supramolecular complexes.
Annu Rev Neurosci
24:1-29[ISI][Medline].
-
Soderling TR
(2000)
CaM-kinases: modulators of synaptic plasticity.
Curr Opin Neurobiol
10:375-380[ISI][Medline].
-
Song I,
Kamboj S,
Xia J,
Dong H,
Liao D,
Huganir RL
(1998)
Interaction of the N-ethylmaleimide-sensitive factor with AMPA receptors.
Neuron
21:393-400[ISI][Medline].
-
Srivastava S,
Osten P,
Vilim FS,
Khatri L,
Inman G,
States B,
Daly C,
DeSouza S,
Abagyan R,
Valtschanoff JG,
Weinberg RJ,
Ziff EB
(1998)
Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA receptor-binding protein ABP.
Neuron
21:581-591[ISI][Medline].
-
Tomita S,
Nicoll RA,
Bredt DS
(2001)
PDZ protein interactions regulating glutamate receptor function and plasticity.
J Cell Biol
153:F19-F24[ISI][Medline].
-
Topinka JR,
Bredt DS
(1998)
N-terminal palmitoylation of PSD-95 regulates association with cell membranes and interaction with K+ channel, Kv1.4.
Neuron
20:125-134[ISI][Medline].
-
Xia J,
Chung HJ,
Wihler C,
Huganir RL,
Linden DJ
(2000)
Cerebellar long-term depression requires PKC-regulated interactions between GluR2/3 and PDZ domain-containing proteins.
Neuron
28:499-510[ISI][Medline].
-
Ziff EB
(1997)
Enlightening the postsynaptic density.
Neuron
19:1163-1174[ISI][Medline].
Copyright © 2002 Society for Neuroscience 0270-6474/02/22145791-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
J. D. Hoffert, R. A. Fenton, H. B. Moeller, B. Simons, D. Tchapyjnikov, B. W. McDill, M.-J. Yu, T. Pisitkun, F. Chen, and M. A. Knepper
Vasopressin-stimulated Increase in Phosphorylation at Ser269 Potentiates Plasma Membrane Retention of Aquaporin-2
J. Biol. Chem.,
September 5, 2008;
283(36):
24617 - 24627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Braiterman, S. Heffernan, L. Nyasae, D. Johns, A. P. See, R. Yutzy, A. McNickle, M. Herman, A. Sharma, U. P. Naik, et al.
JAM-A is both essential and inhibitory to development of hepatic polarity in WIF-B cells
Am J Physiol Gastrointest Liver Physiol,
February 1, 2008;
294(2):
G576 - G588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mendoza-Topaz, F. Urra, R. Barria, V. Albornoz, D. Ugalde, U. Thomas, E. D. Gundelfinger, R. Delgado, M. Kukuljan, P. D. Sanxaridis, et al.
DLGS97/SAP97 Is Developmentally Upregulated and Is Required for Complex Adult Behaviors and Synapse Morphology and Function
J. Neurosci.,
January 2, 2008;
28(1):
304 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shin and D. M. Chetkovich
Activity-dependent Regulation of h Channel Distribution in Hippocampal CA1 Pyramidal Neurons
J. Biol. Chem.,
November 9, 2007;
282(45):
33168 - 33180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bruneau and M. Akaaboune
The Dynamics of the Rapsyn Scaffolding Protein at Individual Acetylcholine Receptor Clusters
J. Biol. Chem.,
March 30, 2007;
282(13):
9932 - 9940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lamprecht and U. Seidler
The emerging role of PDZ adapter proteins for regulation of intestinal ion transport
Am J Physiol Gastrointest Liver Physiol,
November 1, 2006;
291(5):
G766 - G777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. I. Charych, B. F. Akum, J. S. Goldberg, R. J. Jornsten, C. Rongo, J. Q. Zheng, and B. L. Firestein
Activity-Independent Regulation of Dendrite Patterning by Postsynaptic Density Protein PSD-95
J. Neurosci.,
October 4, 2006;
26(40):
10164 - 10176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Deng, M. G. Price, C. F. Davis, M. Mori, and D. L. Burgess
Stargazin and other transmembrane AMPA receptor regulating proteins interact with synaptic scaffolding protein MAGI-2 in brain.
J. Neurosci.,
July 26, 2006;
26(30):
7875 - 7884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Walker, P. J. Brockie, D. M. Madsen, M. M. Francis, Y. Zheng, S. Koduri, J. E. Mellem, N. Strutz-Seebohm, and A. V. Maricq
Reconstitution of invertebrate glutamate receptor function depends on stargazin-like proteins
PNAS,
July 11, 2006;
103(28):
10781 - 10786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nirula, M. Ho, H. Phee, J. Roose, and A. Weiss
Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4
J. Exp. Med.,
July 10, 2006;
203(7):
1733 - 1744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-G. Kang, C.-C. Chen, M. Wakamori, Y. Hara, Y. Mori, and K. P. Campbell
A functional AMPA receptor-calcium channel complex in the postsynaptic membrane
PNAS,
April 4, 2006;
103(14):
5561 - 5566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Palmer, L. Cotton, and J. M. Henley
The Molecular Pharmacology and Cell Biology of {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors
Pharmacol. Rev.,
June 1, 2005;
57(2):
253 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Price, C. F. Davis, F. Deng, and D. L. Burgess
The {alpha}-Amino-3-hydroxyl-5-methyl-4-isoxazolepropionate Receptor Trafficking Regulator "Stargazin" Is Related to the Claudin Family of Proteins by Its Ability to Mediate Cell-Cell Adhesion
J. Biol. Chem.,
May 20, 2005;
280(20):
19711 - 19720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Vandenberghe, R. A. Nicoll, and D. S. Bredt
Stargazin is an AMPA receptor auxiliary subunit
PNAS,
January 11, 2005;
102(2):
485 - 490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Dong, Y.-Y. Xiang, N. Farchi, W. Ju, Y. Wu, L. Chen, Y. Wang, B. Hochner, B. Yang, H. Soreq, et al.
Excessive Expression of Acetylcholinesterase Impairs Glutamatergic Synaptogenesis in Hippocampal Neurons
J. Neurosci.,
October 13, 2004;
24(41):
8950 - 8960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Cuadra, S.-H. Kuo, Y. Kawasaki, D. S. Bredt, and D. M. Chetkovich
AMPA Receptor Synaptic Targeting Regulated by Stargazin Interactions with the Golgi-Resident PDZ Protein nPIST
J. Neurosci.,
August 25, 2004;
24(34):
7491 - 7502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Ives, S. Fung, P. Tiwari, H. L. Payne, and C. L. Thompson
Microtubule-associated Protein Light Chain 2 Is a Stargazin-AMPA Receptor Complex-interacting Protein in Vivo
J. Biol. Chem.,
July 23, 2004;
279(30):
31002 - 31009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tomita, M. Fukata, R. A. Nicoll, and D. S. Bredt
Dynamic Interaction of Stargazin-like TARPs with Cycling AMPA Receptors at Synapses
Science,
March 5, 2004;
303(5663):
1508 - 1511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-G. Kang and K. P. Campbell
{gamma} Subunit of Voltage-activated Calcium Channels
J. Biol. Chem.,
June 6, 2003;
278(24):
21315 - 21318.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Parker, J. R. Backstrom, E. Sanders-Bush, and B.-H. Shieh
Agonist-induced Phosphorylation of the Serotonin 5-HT2C Receptor Regulates Its Interaction with Multiple PDZ Protein 1
J. Biol. Chem.,
June 6, 2003;
278(24):
21576 - 21583.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|